Astaxanthin is a carotenoid produced by different organisms and microorganisms such as microalgae, bacteria, yeasts, protists, and plants, and it is also accumulated in aquatic animals such as fish ...and crustaceans. Astaxanthin and astaxanthin-containing lipid extracts obtained from these sources present an intense red color and a remarkable antioxidant activity, providing great potential to be employed as food ingredients with both technological and bioactive functions. However, their use is hindered by: their instability in the presence of high temperatures, acidic pH, oxygen or light; their low water solubility, bioaccessibility and bioavailability; their intense odor/flavor. The present paper reviews recent advances in the micro/nanoencapsulation of astaxanthin and astaxanthin-containing lipid extracts, developed to improve their stability, bioactivity and technological functionality for use as food ingredients. The use of diverse micro/nanoencapsulation techniques using wall materials of a different nature to improve water solubility and dispersibility in foods, masking undesirable odor and flavor, is firstly discussed, followed by a discussion of the importance of the encapsulation to retard astaxanthin release, protecting it from degradation in the gastrointestinal tract. The nanoencapsulation of astaxanthin to improve its bioaccessibility, bioavailability and bioactivity is further reviewed. Finally, the main limitations and future trends on the topic are discussed.
Myelodysplastic syndromes (MDSs) are a group of heterogeneous clonal hematologic malignancies that are characterized by defective bone marrow (BM) hematopoiesis and by the occurrence of ...intramedullary apoptosis. During the past decade, the identification of key genetic and epigenetic alterations in patients has improved our understanding of the pathophysiology of this disease. However, the specific molecular mechanisms leading to the pathogenesis of MDS have largely remained obscure. Recently, essential evidence supporting the direct role of innate immune abnormalities in MDS has been obtained, including the identification of multiple key regulators that are overexpressed or constitutively activated in BM hematopoietic stem and progenitor cells. Mounting experimental results indicate that the dysregulation of these molecules leads to abnormal hematopoiesis, unbalanced cell death and proliferation in patients' BM, and has an important role in the pathogenesis of MDS. Furthermore, there is compelling evidence that the deregulation of innate immune and inflammatory signaling also affects other cells from the immune system and the BM microenvironment, which establish aberrant associations with hematopoietic precursors and contribute to the MDS phenotype. Therefore, the deregulation of innate immune and inflammatory signaling should be considered as one of the driving forces in the pathogenesis of MDS. In this article, we review and update the advances in this field, summarizing the results from the most recent studies and discussing their clinical implications.
•Lipids from shrimp waste composed of fat, α-tocopherol, cholesterol, and astaxanthin.•C16:0, C18:2n6c, C18:1n9c, C22:6n3, and C20:5n3 fatty acids were the most abundant.•SFA, MUFA, and PUFA ...accounted for ≈31%, ≈25%, and ≈44% of total fatty acids.•All-trans-astaxanthin, 2 cis isomers, 5 astaxanthin monoesters, and 10 diesters found.•Astaxanthin, α-tocopherol gradually degraded upon storage; no lipid oxidation found.
In this work a lipid extract from shrimp waste was obtained and characterized. The most abundant fatty acids found were C16:0, C18:2n6c, C18:1n9c, C22:6n3, and C20:5n3. The extract contained all-trans-astaxanthin, two cis-astaxanthin isomers, 5 astaxanthin monoesters, and 10 astaxanthin diesters (7±1mg astaxanthin/g). C22:6n3 and C20:5n3 were the most frequent fatty acids in the esterified forms. Appreciable amounts of α-tocopherol and cholesterol were also found (126±11mg/g and 65±1mg/g, respectively). Little lipid oxidation was observed after 120days of storage at room temperature, revealed by a slight reduction of ω-3 fatty acids, but neither accumulation of TBARS nor formation of oxidized cholesterol forms was found. This is attributed to the antioxidant effect of astaxanthin and α-tocopherol, as their concentrations decreased as storage continued. The lipid extract obtained has interesting applications as food ingredient, owing to the coloring capacity and the presence of healthy components.
Abstract
STUDY QUESTION
What is the vaginal polymorphonuclear (PMN) spermicidal mechanism to reduce the excess of sperm?
SUMMARY ANSWER
We show that PMNs are very efficient at killing sperm by a ...trogocytosis-dependent spermicidal activity independent of neutrophil extracellular traps (NETs).
WHAT IS KNOWN ALREADY
Trogocytosis has been described as an active membrane exchange between immune cells with a regulatory purpose. Recently, trogocytosis has been reported as a mechanism which PMNs use to kill tumour cells or Trichomonas vaginalis.
STUDY DESIGN, SIZE, DURATION
We used in vivo murine models and human ex vivo sperm and PMNs to investigate the early PMN–sperm response.
PARTICIPANTS/MATERIALS, SETTING, METHODS
We set up a live/dead sperm detection system in the presence of PMNs to investigate in vivo and ex vivo PMN-spermicidal activity by confocal microscopy, flow cytometry and computer-assisted sperm analysis (SCA).
MAIN RESULTS AND THE ROLE OF CHANCE
We revealed that PMNs are highly efficient at killing sperm by way of a NETs-independent, contact-dependent and serine proteases-dependent engulfment mechanism. PMNs ‘bite’ sperm and quickly reduce sperm motility (within 5 min) and viability (within 20 min) after contact.
LARGE SCALE DATA
N/A
LIMITATIONS, REASONS FOR CAUTION
This study was conducted using murine models and healthy human blood PMNs; whether it is relevant to human vaginal PMNs or to cases of infertility is unknown.
WIDER IMPLICATIONS OF THE FINDINGS
Vaginal PMNs attack and immobilize excess sperm in the vagina by trogocytosis because sperm are exogenous and may carry pathogens. Furthermore, this mechanism of sperm regulation has low mucosal impact and avoids an exacerbated inflammatory response that could lead to mucosal damage or infertility.
STUDY FUNDING/COMPETING INTEREST(S)
This work was partially supported by Ministry of Economy and Competitiveness ISCIII-FIS grants, PI16/00050, and PI19/00078, co-financed by ERDF (FEDER) Funds from the European Commission, ‘A way of making Europe’ and IiSGM intramural grant II-PI-MRC-2017. M.R. holds a Miguel Servet II contract (CPII14/00009). M.C.L. holds IiSGM intramural contract. There are no competing interests.
Context.
NIKA2 is a dual-band millimetre continuum camera of 2 900 kinetic inductance detectors, operating at 150 and 260 GHz, installed at the IRAM 30-m telescope in Spain. Open to the scientific ...community since October 2017, NIKA2 will provide key observations for the next decade to address a wide range of open questions in astrophysics and cosmology.
Aims.
Our aim is to present the calibration method and the performance assessment of NIKA2 after one year of observation.
Methods.
We used a large data set acquired between January 2017 and February 2018 including observations of primary and secondary calibrators and faint sources that span the whole range of observing elevations and atmospheric conditions encountered by the IRAM 30-m telescope. This allowed us to test the stability of the performance parameters against time evolution and observing conditions. We describe a standard calibration method, referred to as the “Baseline” method, to translate raw data into flux density measurements. This includes the determination of the detector positions in the sky, the selection of the detectors, the measurement of the beam pattern, the estimation of the atmospheric opacity, the calibration of absolute flux density scale, the flat fielding, and the photometry. We assessed the robustness of the performance results using the Baseline method against systematic effects by comparing results using alternative methods.
Results.
We report an instantaneous field of view of 6.5′ in diameter, filled with an average fraction of 84%, and 90% of valid detectors at 150 and 260 GHz, respectively. The beam pattern is characterised by a FWHM of 17.6″ ± 0.1″ and 11.1″ ± 0.2″, and a main-beam efficiency of 47%±3%, and 64%±3% at 150 and 260 GHz, respectively. The point-source rms calibration uncertainties are about 3% at 150 GHz and 6% at 260 GHz. This demonstrates the accuracy of the methods that we deployed to correct for atmospheric attenuation. The absolute calibration uncertainties are of 5%, and the systematic calibration uncertainties evaluated at the IRAM 30-m reference Winter observing conditions are below 1% in both channels. The noise equivalent flux density at 150 and 260 GHz are of 9 ± 1 mJy s
1/2
and 30 ± 3 mJy s
1/2
. This state-of-the-art performance confers NIKA2 with mapping speeds of 1388 ± 174 and 111 ± 11 arcmin
2
mJy
−2
h
−1
at 150 and 260 GHz.
Conclusions.
With these unique capabilities of fast dual-band mapping at high (better that 18″) angular resolution, NIKA2 is providing an unprecedented view of the millimetre Universe.
Abstract Background and aim Hypertension is one of the main cardiovascular risk factors in the elderly. The aims of this work were to evaluate if a one-year intervention with two Mediterranean diets ...(Med-diet) could decrease blood pressure (BP) due to a high polyphenol consumption, and if the decrease in BP was mediated by plasma nitric oxide (NO) production. Methods and results An intervention substudy of 200 participants at high cardiovascular risk was carried out within the PREDIMED trial. They were randomly assigned to a low-fat control diet or to two Med-diets, one supplemented with extra virgin olive oil (Med-EVOO) and the other with nuts (Med-nuts). Anthropometrics and clinical parameters were measured at baseline and after one year of intervention, as well as BP, plasma NO and total polyphenol excretion (TPE) in urine samples. Systolic and diastolic BP decreased significantly after a one-year dietary intervention with Med-EVOO and Med-nuts. These changes were associated with a significant increase in TPE and plasma NO. Additionally, a significant positive correlation was observed between changes in urinary TPE, a biomarker of TP intake, and in plasma NO (Beta = 4.84; 95% CI: 0.57–9.10). Conclusions TPE in spot urine sample was positively correlated with plasma NO in Med-diets supplemented with either EVOO or nuts. The statistically significant increases in plasma NO were associated with a reduction in systolic and diastolic BP levels, adding to the growing evidence that polyphenols might protect the cardiovascular system by improving the endothelial function and enhancing endothelial synthesis of NO.
Although milk polar lipids such as phospholipids and sphingolipids located in the milk fat globule membrane constitute 0.1 to 1% of the total milk fat, those lipid fractions are gaining increasing ...interest because of their potential beneficial effects on human health and technological properties. In this context, the accurate quantification of the milk polar lipids is crucial for comparison of different milk species, products, or dairy treatments. Although the official International Organization for Standardization-International Dairy Federation method for milk lipid extraction gives satisfactory results for neutral lipids, it has important disadvantages in terms of polar lipid losses. Other methods using mixtures of solvents such as chloroform:methanol are highly efficient for extracting polar lipids but are also associated with low sample throughput, long time, and large solvent consumption. As an alternative, we have optimized the milk fat extraction yield by using a pressurized liquid extraction (PLE) method at different temperatures and times in comparison with those traditional lipid extraction procedures using 2:1 chloroform:methanol as a mixture of solvents. Comparison of classical extraction methods with the developed PLE procedure were carried out using raw whole milk from different species (cows, ewes, and goats) and considering fat yield, fatty acid methyl ester composition, triacylglyceride species, cholesterol content, and lipid class compositions, with special attention to polar lipids such as phospholipids and sphingolipids. The developed PLE procedure was validated for milk fat extraction and the results show that this method performs a complete or close to complete extraction of all lipid classes and in less time than the official and Folch methods. In conclusion, the PLE method optimized in this study could be an alternative to carry out milk fat extraction as a routine method.
A functional concentrate rich in proteins and lipids was obtained from an industrial shrimp cooking juice by using a centrifugal separator, and it was characterized in terms of chemical composition ...parameters and functional or biological activity (antioxidant and ACE-inhibitory capacities). The concentrate presented 116 g/kg protein, 135 g/kg crude fat and ash content less than 10 g/kg, with predominance of Na ions, followed by K, Ca, Mg, Cu, Fe, Zn and Mn. A relative abundance of glucose, glycerol, polyalcohols, acetate and phosphate was found. The antioxidant (as determined by ABTS, FRAP, chelating and photoluminescence assays) and ACE-inhibitory capacities of the material recovered from the shrimp cooking juice were strongly related to the presence of small peptides (1355–502 Da), with a clear predominance of Gly, Pro, Glu, Asp and Arg. Other antioxidants, such as free astaxanthin (cis and trans isomers) and derived esters, were also detected.
•Material from shrimp cooking juice with antioxidant and ACE-inhibitory capacities.•Compositional properties of a functional concentrate were reported.•Peptides rich in Gly and Pro were responsible for high ACE-inhibitory capacity.•Free astaxanthin and derived esters were detectable in the cooking juice.
The safety of thiopurines and anti-tumor necrosis factor-α (TNF-α) drugs during pregnancy remains controversial, as the experience with these drugs in this situation is limited. Our aim is to assess ...the safety of thiopurines and anti-TNF-α drugs for the treatment of inflammatory bowel disease (IBD) during pregnancy.
Retrospective, multicenter study in IBD patients. Pregnancies were classified according to the therapeutic regimens during pregnancy or during the 3 months before the conception: non-exposed group, pregnancies exposed to thiopurines alone (group A), and pregnancies exposed to anti-TNF-α drugs (group B). An unfavorable Global Pregnancy Outcome (GPO) was considered if pregnancy developed with obstetric complications in the mother and in the newborn.
A total of 187 pregnancies in the group A, 66 pregnancies in the group B, and 318 pregnancies in the non-exposed group were included. The rate of unfavorable GPO was different among the three groups (31.8% in non-exposed group, 21.9% in group A, and 34.8% in group B), being lower in pregnancies under thiopurines than among non-exposed (P = 0.01). The rate of pregnancy complications was similar among the three groups (27.7% in non-exposed, 20.9% in group A, and 30.3% in group B). The rate of neonatal complications was different among the three groups (23.3% in non-exposed group, 13.9% in group A, and 21.2% in group B), being lower in pregnancies under thiopurines than among non-exposed (P = 0.01). In the multivariate analysis, the treatment with thiopurines (odds ratio = 0.6; 95% confidence interval = 0.4-0.9, P = 0.02) was the only predictor of favorable GPO, whereas maternal age >35 years at conception was the only predictor of unfavorable GPO. The treatment with anti-TNF-α drugs was not associated with an unfavorable GPO.
The treatment with thiopurines and anti-TNF-α drugs does not seem to increase the risk of complications during pregnancy and does seem to be safe for the newborn.
Urban Health Equity Assessment and Response Tool (HEART) is a tool developed by the World Health Organization whose objective is to provide evidence on urban health inequalities so as to help to ...decide the best interventions aimed to promote urban health equity. The aim of this paper is to describe the experience of implementing Urban HEART in Barcelona city, both the adaptation of Urban HEART to the city of Barcelona, its use as a means of identifying and monitoring health inequalities among city neighbourhoods, and the difficulties and barriers encountered throughout the process. Although ASPB public health technicians participated in the Urban HEART Advisory Group, had large experience in health inequalities analysis and research and showed interest in implementing the tool, it was not until 2015, when the city council was governed by a new left-wing party for which reducing health inequalities was a priority that Urban HEART could be used. A provisional matrix was developed, including both health and health determinant indicators, which allowed to show how some neighbourhoods in the city systematically fare worse for most of the indicators while others systematically fare better. It also allowed to identify 18 neighbourhoods—those which fared worse in most indicators—which were considered a priority for intervention, which entered the Health in the Barcelona Neighbourhoods programme and the Neighbourhoods Plan. This provisional version was reviewed and improved by the Urban HEART Barcelona Working Group. Technicians with experience in public health and/or in indicator and database management were asked to indicate suitability and relevance from a list of potential indicators. The definitive Urban HEART Barcelona version included 15 indicators from the five Urban HEART domains and improved the previous version in several requirements. Several barriers were encountered, such as having to estimate indicators in scarcely populated areas or finding adequate indicators for the physical context domain. In conclusion, the Urban HEART tool allowed to identify urban inequalities in the city of Barcelona and to include health inequalities in the public debate. It also allowed to reinforce the community health programme Health in the Barcelona Neighbourhoods as well as other city programmes aimed at reducing health inequalities. A strong political will is essential to place health inequalities in the political agenda and implement policies to tackle them.
PDF
